Transmission
A deadly viral infection caused by the virus ebola, that leads to profuse internal and external bleeding and eventually leading to organ failure.
Urgent medical attention is usually recommended by healthcare providers
May be dangerous or life threatening
Extremely rare (Zero cases in US in 2015)
Treatments can help manage condition, no known cure
Often requires lab test or imaging
Transmitted through direct contact
Symptoms
Diagnosis
Treatment
Vaccines
It is thought that fruit bats of the Pteropodidae family are natural Ebola virus hosts. Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals such as fruit bats,chimpanzees, gorillas, monkeys, forest antelope or porcupines found ill or de…
Prevention and Control
- The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is from 2 to 21 days. A person infected with Ebola cannot spread the disease until they develop symptoms. Symptoms of EVD can be sudden and include: 1. Fever 2. Fatigue 3. Muscle pain 4. Headache 5. Sore throat This is followed by: 1. Vomiting 2. Diarrhoea 3. Rash 4. Symptoms of i…
Controlling Infection in Health-Care Settings
- It can be difficult to clinically distinguish EVD from other infectious diseases such as malaria, typhoid fever and meningitis. Many symptoms of pregnancy and Ebola disease are also quite similar. Because of risks to the pregnancy, pregnant women shouldideally be tested rapidly if Ebola is suspected. Confirmation that symptoms are caused by Ebola virus infection are made u…
Care For People Who Recovered from EVD
- Supportive care - rehydration with oral or intravenous fluids - and treatment of specific symptoms improves survival. A range of potential treatments including blood products, immune therapies and drug therapies are currently being evaluated. In the 2018-2020 Ebola outbreak in the Democratic Republic of the Congo, the first-ever multi-drug randomized control trialwas conduct…
Who Response
- The Ervebo vaccine has been shown to be effective in protecting people from the species Zaire ebolavirus, and is recommended by the Strategic Advisory Group of Experts on Immunization as part of a broader set of Ebola outbreak response tools. In December 2020, the vaccine was approved by the US Food and Drug Administration and prequalifiedby WHO for use in individual…